1. Background {#sec39951}
=============

Cancer is one of the leading causes of mortality worldwide (about 13% of all mortalities) ([@A16615R1]) and its incidence has globally increased to more than two times during the past 30 years ([@A16615R2]). Breast cancer is one of the most common cancers amongst women worldwide (about 23% of all cancers) and it is the first cause of mortality due to cancer among women ([@A16615R3]). The annual incidence of breast cancer is steadily increasing and this ascending process has a higher rate in countries with low breast cancer incidence ([@A16615R4]). In Iran, breast cancer is the most common cancer among women, and studies have shown that it accounts for 24.4% of all neoplasms ([@A16615R5]) with a crude incidence rate of 17.81 ([@A16615R6], [@A16615R7]).

Breast cancer incidence is increasing in Iran. Despite development of diagnostic methods, still many patients are diagnosed at developed stages ([@A16615R8], [@A16615R9]) , Based on the comparative reports, the mean age of Iranian women with breast cancer (with a mean age of 47.1 to 48.8) is at least 10 years younger than the women with the same malignancy in developed countries ([@A16615R8], [@A16615R10]). Thus, the early diagnosis of breast cancer plays an important role in a better prognosis and consequently leaded to a reduced mortality rate. Mammography, as the method of choice for population-based breast cancer screening, aims to detect cancer at asymptomatic stages that the treatment is easier with better outcomes ([@A16615R11]). The screening programs in some countries have proved this claim ([@A16615R12]).

Various environmental and genetic factors have been approved to affect the susceptibility of breast cancer. According to 2008 WHO report, breast cancer is associated with nulliparity, first delivery at an old age, early menarche and late menopause. Using oral contraception pills (OCP) and Hormone Replacement Therapy (HRT) are also reported to be associated with an increased risk of breast cancer. Family history of breast cancer and high mammography density are two breast cancer risk factors which help to detect high risk women in screening programs ([@A16615R2]).

As mentioned before, mammography is the recommended screening method for early detection of breast cancer which has a high potency in detecting suspicious lesions. On the other hands, it helps to identify high risk women by determining mammographic breast density. Breast density higher than 75% is associated with a 4-6 folds increase in breast cancer risk ([@A16615R13], [@A16615R14]).

There are several methods to estimate mammographic density of mammograms including qualitative methods such as Wolfe grade, BIRADS classification, Tabar grade, and six-category classification, as well as quantitative method (computer-assisted threshold method) ([@A16615R15]). Qualitative methods are observer-base but these methods do not have the limitations that the quantitative methods do, for instance, the tumor volume assessment and estimation from two-dimensional images is possible, because the observer can reconstruct a three-dimensional image of the breast and densities, out of images taken in two different views, in his mind. On the other hand, many common ([@A16615R16], [@A16615R17]) and uncommon ([@A16615R18], [@A16615R19]) benign and malignant lesions may be presented as dense lesions in mammography images that may be ignored in qualitative methods by the physician when estimating the underlying breast tissue density, but this would not be happened using automated methods. In large or multiple lesion cases, the breast density will be falsely diagnosed.

New methods are being developed to minimize such limitations. Further studies should be done to prove the density, estimated by these methods ([@A16615R15]). One the most common qualitative methods used to define the breast density is BIRADS classification which was also used in our study.

2. Objectives {#sec39952}
=============

We expect a higher breast density in women at higher risk of breast cancer, thus it would be associated with other breast cancer risk factors. Few studies have been performed on mammographic density in Iran ([@A16615R20]-[@A16615R22]), none of which have been allocated to the epidemiologic distribution of mammographic density. Regarding the difference in prevalence of dense breasts and life style in each population, the determinants of breast density differ in each country. So we decided to assess the distribution of this factor among Iranian population and evaluate its association with other risk factors and factors that may affect breast density based on previous studies.

3. Materials and Methods {#sec39957}
========================

3.1. Study Design and Sampling {#sec39953}
------------------------------

This was an analytical cross-sectional study carried out in Tehran, Iran in order to estimate breast density distribution and investigate its determinants in Iranian women. 728 of those who had referred to imaging center of Imam Khomeini Cancer Institute either for diagnosing or screening purposes, were participated in this study, after filling out the informed consent form, the questionnaire based survey, assessing breast cancer risk factors affecting the breast density and related demographic features, was conducted. Inclusion criteria: Accessibility to mammographic report, including mammographic density, reported by one of the three radiologists participating in this study. Exclusion criteria: Individuals with a history of bilateral breast cancer were excluded from the study. Cases with a history of unilateral breast cancer, the mammographic information of the contra lateral breast was included in the analysis. Those who had not filled out the informed consent form or the questionnaire or had no accessible mammographic information were excluded.

3.2. Sample Size {#sec39954}
----------------

Based on the prevalence of dense breasts in literature ([@A16615R23], [@A16615R24]), the minimum estimated sample size, was 380 that was increased to 800, considering the design effect (with the assumption of 2 for DF and a power of 80% at 5% significance level). Sixty three questionnaires were not filled out, that indicate a response rate of around 92%.

3.3. Measures {#sec39955}
-------------

According to literature, different variables which may affect the breast density and breast cancer risk factors were determined and demographic questionnaire was designed. This was a 20-item questionnaire including questions of ages, weight, height, marital status, occupational status, obstetric information (menarche age, menopause age, parity number, age at first delivery, etc.) breast cancer risk factors (personal and family history of breast cancer, OCP consumption, etc.) and other factors seem to affect density (ovarian cycle phase, using calcium, etc.).

During one month, about 60 patients participated in a pilot study and evaluations regarding missed data were conducted. Necessary revisions were taken into account to decrease missed data.

Mammographic density was reported by three expert radiologists using BI-RDAS standards lexicon. According to BIRADS lexicon breast density is classified into four groups: ACR I (almost entirely fat or fibro glandular tissue (FGT) \< 25%), ACR II (scattered fibro glandular densities or FGT of 25-50%), ACR III (heterogeneously dense or FGT of 50-75%) and ACR IV (extremely dense or FGT \> 75%) ([@A16615R25]). Reporters are all colleagues who work in the same center. All mammograms (full-digital two-view ones) were taken with the same technique and read on the same system.

3.4. Analysis {#sec39956}
-------------

More than one observer participated in the study; an assessment of the inter-observer agreement was required to analyze the data. In another study, conducted by the authors in the same center, inter and intra-observers variability in interpreting mammograms was evaluated by three radiologists. Based on the results of this study, inter-observer agreement in reporting density is good (kappa = 0.701). Our results are comparable with another study that recently carried out in Isfahan, Iran ([@A16615R11]), showing an extensive agreement among reporters in defining the type of density (Kappa = 0.74). So, it was reasonable to perform one analysis for all samples. This procedure was separately done in both diagnostic and screening groups. Descriptive statistics including frequency, percentage, mean and standard deviations were used to describe the study sample.

The dependent variable (mammographic density) was categorized into two levels: low density breast tissue (breast density of ACR groups 1 and 2) and high density breast tissue (breast density of ACR groups 3 and 4). The independent variables were compared in groups. To compare the continuous data, t-test was used. The association of categorical data and density was analyzed by chi-square and Fisher\'s exact test. For categorical data another analysis using t-test was performed to compare mean density percentage between the two groups. A P-value of less than 0.05 was considered statistically significant. Both univariate and multiple logistic regression analysis were performed to examine the association between density and independent variables. Data were analyzed using the SPSS statistics software version 11.5. The study has been approved by the ethics committee of Tehran University of Medical Sciences. The written informed assent was taken from all participators.

4. Results {#sec39972}
==========

4.1. The Study Sample {#sec39958}
---------------------

728 women participated in the study amongst 184 (25.3%) had undertaken mammography for diagnostic and 542 (74.7%) for screening purposes. Out of 542 patients, 210 (38.7%) mammograms were done for the first time and 332 (61.3%) for follow up.

The mean age of participants was 48.12 (SD = 8.66) ranging from 19 to 83 years. Participants\' age distribution had normal distribution. 57.1% of participants had one of the symptoms including pain, feeling mass or thickness in the breast, bloody or watery discharge, pruritus, erythema or nipple retraction. 37.4% of them experienced the symptoms in left, 28.8% in the right breast and 33.8% have bilaterally pain. 57.8% of the patients in screening group were asymptomatic and 2.2% were in diagnostic group. 94.1% of the study sample were married; 41 (5.6%) had personal history of breast cancer and 170 (24.5%) had positive family history of breast cancer. The demographic features of the samples are shown in [Table 1](#tbl10523){ref-type="table"}. There was a significant difference between diagnostic and screening groups in some factors including age, breast density, personal history of breast cancer, using HRT and menopausal status.

###### Demographic Feature of the Study

                                     Total (n=728) Mean ± SD   Screening (n=544) Mean ± SD   Diagnostic Mean ± SD   P OR (95% CI)
  ---------------------------------- ------------------------- ----------------------------- ---------------------- -------------------------
  **Age (y)**                        48.1 ± 8.6                48.6 ± 8.3                    46.6 ± 9.4             0.012
  **BMI**                            27.9 ± 5.4                27.8 ± 4.8                    28.3 ± 7.0             0.408
  **Density (percent)**              48.9 ± 21.5               47.7 ± 21.4                   52.5 ± 21.3            0.009
  **Menarche age**                   13.5 ± 1.5                13.5 ± 1.5                    13.5 ± 1.4             0.594
  **Parity number**                  2.8 ± 1.8                 2.8 ± 1.7                     3.0 ± 2.3              0.140
  **First birth age**                21.5 ± 4.8)               21.6 ± 4.8                    21.1 ± 4.7             0.268
  **Menopause age**                  47.2 ± 5.6                47.3 ± 5.4                    47.1 ± 6.2             0.890
  **FH of breast cancer positive**                                                                                  0.087
  First degree                       70 ± 10.1                 57 ± 10.9                     13 ± 7.5               
  Second degree                      87 ± 12.5                 68 ± 13.1                     19 ± 11.0              
  Both                               13 ± 1.9                  11 ± 2.1                      2 ± 1.2                
  Negative                           524 ± 75.5                385 ± 73.9                    139 ± 80.3             
  **FH of other cancers positive**                                                                                  0.123
  First degree                       73 ± 11.3                 56 ± 11.5                     17 ± 10.3              
  Second degree                      69 ± 10.8                 57 ± 11.7                     12 ± 7.2               
  \>1 positive FH                    18 ± 3.1                  17 ± 3.4                      138 ± 83.1             
  Negative                           513 ± 78.9                375 ± 77.5                    1 ± 0.6                
  **Personal Hx of breast cancer**                                                                                  0.046, 2.55 (0.98-6.6)
  Positive                           41 ± 5.6                  36 ± 6.6                      5 ± 2.7                
  Negative                           687 ± 94.4                508 ± 93.4                    179 ± 97.3             2.55 (0.98-6.6)
  **Marital status**                                                                                                0.850
  Single                             41 ± 5.9                  30 ± 5.8                      11 ± 6.2               
  Married                            651 ± 94.1                485 ± 94.2                    166 ± 93.8             
  **Breast feeding yes**                                                                                            0.510
  Complete                           379 ± 60.9                285 ± 60.0                    94 ± 63.9              
  Incomplete                         176 ± 28.3                141 ± 29.7                    35 ± 23.9              
  Never                              67 ± 10.8                 49 ± 10.3                     18 ± 12.2              
  **Using OCP yes**                                                                                                 0.895
  Already                            229 ± 36.9                180 ± 37.3                    49 ± 35.5              
  Still yes                          17 ± 2.7                  12 ± 2.5                      5 ± 3.6                
  Never                              375 ± 60.4                291 ± 60.2                    84 ± 60.9              
  **Using HRT yes**                                                                                                 0.033, 2.70 (1.05-6.98)
  Already                            23 ± 3.2                  22 ± 4.0                      1 ± 0.5                
  Still yes                          20 ± 2.7                  16 ± 3.0                      4 ± 2.2                
  Never                              683 ± 94.1                504 ± 93.0                    179 ± 97.3             
  **Using Ca/Vitamin D**                                                                                            0.176
  Ca                                 14 ± 1.9                  12 ± 2.2                      2 ± 1.1                
  Both                               8 ± 1.1                   4 ± 0.7                       4 ± 2.2                
  None                               706 ± 97.0                528 ± 97.1                    178 ± 96.7             
  **Menopausal status**                                                                                             0.004, 1.70(1.18-2.44)
  Yes                                274 ± 37.7                221 ± 40.7                    53 ± 28.8              
  No                                 453 ± 62.3                322 ± 60.3                    131 ± 71.2             
  **Employment status**                                                                                             0.437
  Not employed                       479 ± 77.0                367 ± 76.3                    112 ± 79.4             
  Occupied                           111 ± 17.9                86 ± 17.9                     25 ± 17.8              
  Retired                            32 ± 5.1                  28 ± 5.8                      4 ± 2.8                
  **Smoking**                                                                                                       0.962
  No                                 469 ± 72.2                361 ± 72.2                    108 ± 72.0             
  Yes, passive smoker                161 ± 24.7                123 ± 24.6                    38 ± 25.3              
  Smoker                             20 ± 3.1                  16 ± 3.2                      4 ± 2.7                
  **Radiotherapy Hx**                                                                                               0.335
  Yes                                43 ± 6.0                  35 ± 6.5                      8 ± 4.5                
  No                                 670 ± 94.0                502 ± 93.5                    168 ± 95.5             
  **Mammographic density**                                                                                          0.017, 0.66 (0.47-0.93)
  Low density ACR I                  108 ± 15.3                87 ± 16.5                     21 ± 11.8              
  ACR II                             231 ± 32.8                180 ± 34.3                    51 ± 28.6              
  High density ACR III               301 ± 42.8                217 ± 41.2                    84 ± 47.2              
  ACR IV                             64 ± 9.1                  42 ± 8.0                      22 ± 12.4              

4.2. Breast Density Distribution Among Participants {#sec39959}
---------------------------------------------------

The Mean mammographic density of the participants was estimated 48.9%, in the categories four of ACR mammographic density these amounts were 15.3%, 32.8%, 42.8% and 9.1% respectively. Most of the patients (75%) were among categories 2 and 3 of mammographic density and dense breasts (ACR 3 and 4) were 51.9%; however this amount was lessened in screening mammograms (49.2%) and in diagnostic group were even more (51.6%), but statistically significant difference was observed (P = 0.017, OR = 0.66, 95 CI = 0,47-0,93). The mean density in diagnostic and screening group was 52.5% and 47.7% respectively and t-test showed significant difference between them (P = 0.009, T = 2.619).

4.3. Factors Affecting Breast Density {#sec39960}
-------------------------------------

Age: the distribution of breast density in different aging groups shows that in younger age groups (15-50 years old) high density breasts were more than low density breasts and in older age groups (51-58 years old) this proportion is reversed and the difference of dense breasts between the two age groups is significant (P \< 0.001). On the other hand the results showed that in both screening and diagnostic groups, the mean age is significantly different in both groups of high and low density breasts. [Table 2](#tbl10524){ref-type="table"} separately compares different risk factors according to breast density in both diagnostic and screening groups.

4.4. Breast Feeding {#sec39961}
-------------------

The chi-square test showed no significant difference in breast feeding behaviors in two breast density groups, but t-test proved that mean density was significantly higher in those without any history of breast feeding (56.7%) compared to those with a history of two years of breast feeding (48.9%) or any duration of breast feeding (48.4%) (P = 0.007 and 0.003 respectively). T-test in diagnostic group showed no relation (P = 0.071); but in screening group we found this relation (P = 0.020).

4.5. Menopausal Status {#sec39962}
----------------------

Results in [Table 2](#tbl10524){ref-type="table"} shows there is association between menopausal status and density in both screening and diagnostic groups. Mean density of premenopausal women (53.7%) was also significantly higher (P \< 0.001) than menopausal women (41.1%). The same results were driven from t-test in diagnostic (P \< 0.001) and screening groups (P \< 0.001).

4.6. Marital Status {#sec39963}
-------------------

Chi-square test determined an association between marital status and breast density in the screening but not the diagnostic group. However, t-test proved this relation to exist in both screening (P = 0.001) and diagnostic (P = 0.023) groups.

4.7. Parity {#sec39964}
-----------

Analysis showed there is an association between nulliparity and dense breast tissue in diagnostic groups (P = 0.044) but not in the screening one (P = 0.401). T-test showed there is a reverse relationship between parity number and breast density in both groups ([Table 2](#tbl10524){ref-type="table"}). According to t-test comparing mean breast density in nullipar women (50.7%) with other women (48.1%), the difference was significant (P \< 0.001) and this relationship remains significant in higher parity number cut points,(up to the 8th parity).

4.8. HRT {#sec39965}
--------

Cross tab analysis in screening and diagnostic groups, demonstrated that there was no significant association between breast density of those who currently and/or previously received HRT and those without a history of HRT. Indeed all the analyses were repeated only for menopausal women, which introduced the same result.

###### Association of Density and Breast Cancer Risk Factors in Diagnostic and Screening Groups

                                     Screening (n=544) Mean ± SD   P-value OR (95% CI)   Diagnostic (n=184) Mean ± SD                                   P-value OR (95% CI)                  
  ---------------------------------- ----------------------------- --------------------- -------------------------------------------------------------- --------------------- -------------- --------------------------------------------------------------
  **Age, (y)**                       46.41 ± 7.5                   50.78 ± 8.4           \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=6.252)          44.39 ± 8.3           49.87 ± 10.1   \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=3.914)
  **BMI**                            26.82 ± 4.76                  28.86 ± 4.7           \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=4.294)          27.62 ± 7.6           29.58 ± 5.6    0.171^[a](#fn6878){ref-type="table-fn"}^, (t=1.377)
  **Menarche age**                   13.53 (1.5)                   13.59 (1.4)           0.667^[a](#fn6878){ref-type="table-fn"}^, (t=0.431)            13.50 (1.4)           13.96 (4.3)    0.341^[a](#fn6878){ref-type="table-fn"}^, (t=0.954)
  **Parity number**                  2.35 (1.5)                    3.19 (1.7)            \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=5.766)          2.48 (1.9)            3.86 (2.6)     \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=3.937)
  **First birth age**                22.67 (5.0)                   20.59 (4.4)           \<0.001^[a](#fn6878){ref-type="table-fn"}^, (t=-4.578)         21.57 (5.1)           20.33 (3.7)    0.156^[a](#fn6878){ref-type="table-fn"}^, (t=-1.426)
  **Last birth age**                                                                                                                                                                         
  **Menopause age**                  47.30 (4.7)                   47.24 (5.8)           0.944^[a](#fn6878){ref-type="table-fn"}^, (t=-0.071)           46.04 (6.4)           47.71 (6.3)    0.341^[a](#fn6878){ref-type="table-fn"}^, (t=0.960)
  **Ovarian cycle length**                                                                                                                                                                   
  **FH of breast cancer**                                                                                                                                                                    0.516^[b](#fn6879){ref-type="table-fn"}^
  Positive                           64 (25.2)                     68 (26.3)             0.784^[b](#fn6879){ref-type="table-fn"}^                       18 (18.0)             15 (22.1)      
  Negative                           190 (74.8)                    191 (73.7)                                                                           82 (82.0)             53 (77.9)      
  **FH of Other Cancers**                                                                0.632^[b](#fn6879){ref-type="table-fn"}^                                                            0.074^[b](#fn6879){ref-type="table-fn"}^
  Positive                           50 (21.7)                     58 (23.6)                                                                            20 (21.1)             7 (10.4)       
  Negative                           180 (78.3)                    188 (76.4)                                                                           75 (78.9)             60 (89.6)      
  **Personal Hx of breast cancer**                                                       0.925^[b](#fn6879){ref-type="table-fn"}^                                                            0.650^[c](#fn6880){ref-type="table-fn"}^
  Positive                           18 (6.9)                      18 (6.7)                                                                             4 (3.8)               1 (1.4)        
  Negative                           241(93.1)                     249 (93.3)                                                                           102 (96.2)            71 (98.6)      
  **Marital status**                                                                     0.027^[b](#fn6879){ref-type="table-fn"}^, 0.41(0.18-0.92)                                           0.529^[c](#fn6880){ref-type="table-fn"}^
  Single                             20 (8.0)                      9 (3.5)                                                                              8 (8.7)               3 (4.4)        
  Married                            229 (92.0)                    250 (96.5)                                                                           95 (92.2)             65 (95.6)      
  **Nulliparity**                                                                        0.401^[b](#fn6879){ref-type="table-fn"}^                                                            0.044^[b](#fn6879){ref-type="table-fn"}^, 0.23 (0.05-1.08)
  Yes                                22 (9.4)                      18 (7.3)                                                                             12 (12.0)             2 (3.1)        
  No                                 212 (90.6)                    229 (92.7)                                                                           88 (88.0)             63 (96.9)      
  **Breast feeding**                                                                     0.434^[b](#fn6879){ref-type="table-fn"}^                                                            0.622^[b](#fn6879){ref-type="table-fn"}^
  Yes                                202 (88.6)                    217 (90.8)                                                                           80 (87.0)             44 (89.8)      
  Never                              26 (11.4)                     22 (9.2)                                                                             12 13.0)              5 (10.2)       
  **Using OCP**                                                                          0.680^[b](#fn6879){ref-type="table-fn"}^                                                            0.957^[b](#fn6879){ref-type="table-fn"}^
  Yes                                93 (39.1)                     140 (59.1)                                                                           34 (40.5)             20 (40)        
  Never                              145 (60.9)                    97 (40.9)                                                                            50 (59.5)             30 (60)        
  **Using HRT**                                                                          0.216^[b](#fn6879){ref-type="table-fn"}^                                                            0.366^[c](#fn6880){ref-type="table-fn"}^
  Yes                                15 (5.8)M                     23 (8.6)                                                                             2 (1.9)               3(4.2)         
  No                                 243 (94.2)                    244 (91.4)                                                                           104 (98.1)            69 (95.8)      
  **Using calcium**                                                                      0.144^[b](#fn6879){ref-type="table-fn"}^                                                            1.000^[c](#fn6880){ref-type="table-fn"}^
  Yes                                5 (1.9)                       11 (4.1)                                                                             4 (3.8)               2 (2.8)        
  No                                 254 (98.1)                    256 (95.9)                                                                           102 (96.2)            70 (97.2)      
  **Menopausal status**                                                                  \<0.001^[b](#fn6879){ref-type="table-fn"}^, 0.32 (0.22-0.46)                                        \<0.001^[b](#fn6879){ref-type="table-fn"}^, 0.29 (0.15-0.57)
  Yes                                73 (28.2)                     147 (55.1)                                                                           19 (17.9)             31(43.1)       
  No                                 186 (71.8)                    120 (44.9)                                                                           87 (82.1)             41 (56.9)      
  **Employment status**                                                                  0.001^[b](#fn6879){ref-type="table-fn"}^, 2.06 (1.34-3.18)                                          0.017^[b](#fn6879){ref-type="table-fn"}^, 3.7 (1.2-11.4)
  Not employed                       164 (69.5)                    197 (82.4)                                                                           68 (73.9)             42 (91.3)      
  Employed                           72 (30.5)                     42 (17.6)                                                                            24 (26.1)             4 (8.7)        
  **Smoking**                                                                            0.040^[b](#fn6879){ref-type="table-fn"}^, 0.32(0.1-1.0)                                             0.630^[c](#fn6880){ref-type="table-fn"}^
  No                                 181 (97.8)                    172 (93.5)                                                                           68 (97.1)             40 (95.2)      
  Smoker                             4 (2.2)                       12 (6.5)                                                                             2 (2.9)               2 (4.8)        
  **Radiotherapy Hx**                                                                    0.811^[b](#fn6879){ref-type="table-fn"}^                                                            1.000^[c](#fn6880){ref-type="table-fn"}^
  Yes                                16 (6.3)                      18 (6.8)                                                                             4 (3.9)               3 (4.4)        
  No                                 239 (93.7)                    247 (93.2)                                                                           99 (96.1)             65 (95.6)      
  **Cycle phase**                                                                        0.181^[b](#fn6879){ref-type="table-fn"}^                                                            0.310^[c](#fn6880){ref-type="table-fn"}^
  Follicular                         64 (52.5)                     33 (63.5)                                                                            31 (64.6)             5 (45.5)       
  Luteal                             58 (47.5)                     19 (36.5)                                                                            17 (35.4)             6 (54.5)       

^a^Derived from *t*-test

^b^Derived from Chi-square

^c^Derived from Fisher Exact test

4.9. OCP {#sec39966}
--------

As showed in [Table 2](#tbl10524){ref-type="table"}, analysis presented no association between breast density and current and/or previous use of OCP in each group.

4.10. Smoking {#sec39967}
-------------

In screening group, 51.3% of those who had no exposure to the smoke (non-smokers) and 25% of smokers had dense breasts and their difference was significant (P=0.040), but not in screening group. The Mean breast density among non-smokers was significantly higher (50.2%) than smokers (37.5%) (P = 0.012).

4.11. Ovarian Cycle Phase {#sec39968}
-------------------------

According to cycle length and LMP (last menstrual period) date and the date of referral for mammographic examination, and considering the regularity of the cycle, menstrual cycle phase at the time of mammography was determined. Those with irregular cycles or incomplete information were not included in the analysis. Neither in screening nor the diagnostic group, had not any density associated to the cycle phase ([Table 2](#tbl10524){ref-type="table"}).

4.12. Employment Status {#sec39969}
-----------------------

In the screening group, the frequency of dense breasts among housewives (45.4%), currently employed women (67.4%) and employed or retired women (63.2%) was compared and significant difference was demonstrated between the mentioned groups (P = 0.016 and P = 0.017 in sequence). in diagnostic group 61.8% of housewives had dense breasts which was significantly lower than dense breasts in currently employed (87.5%, P \< 0.001) and retired ones (85.7%, P \< 0.001).

4.13. BMI {#sec39970}
---------

BMI distribution in four ACR density categories is shown ([Figure 1](#fig8329){ref-type="fig"}). In the screening group the mean BMI in high density breast group (26.8) was significantly less than that individuals with low breast density (28.9) and the difference was significant (P \< 0.001). In the diagnostic group the above mentioned association, did not exist.

![BMI Distribution According to Density](ircmj-15-16615-i001){#fig8329}

4.14. First Delivery Age {#sec40018}
------------------------

Mean age at first delivery in screening group was 22.7 in high breast density group which was significantly (P \< 0.001) higher than low breast density group (20.59) but in diagnostic group this amount was 21.6 and 20.3 years, respectively and the differences were not significant (P = 0.156). Mean breast density was significantly different in women with a first delivery age older and younger than 20 years old (P \< 0.001) and this difference was significant up to first delivery age of 29.

4.15. Menopause age, Menarche age, Age at Last Delivery and Cycle Length {#sec39971}
------------------------------------------------------------------------

None of the above mentioned factors showed association with breast density in neither diagnostic nor the screening groups ([Table 2](#tbl10524){ref-type="table"}). Considering the fact that the association of some of these factors with breast density may affect it through some other ones, binary and multiple logistic regression tests were administered to investigate the interactive effect of these factors on density. Binary logistic regression analysis showed that menopausal status, parity and age at the first delivery were independently associated with breast density ([Table 3](#tbl10525){ref-type="table"}). Multiple logistic regression test revealed that only menopausal status had association with breast density (P = 0.003).

###### Results of Logistic Regression Analysis for Breast Density

                          Screening (n=544)                       Diagnostic (n=184)        Total (n=728)                                                                                   
  ----------------------- --------------------------------------- ------------------------- --------------------------- --------------------------------------- --------------------------- ---------------------------
  **Age**                 \<0.001, 0.93 (0.91-0.95)               0.558, 1.01 (0.97-1.07)   \<0.001, 0.93(0.9-0.97)     0.921, 0.997 (0.942-1.056)              \<0.001, 0.93 (0.91-0.95)   0.400, 1.02 (0.98-1.07)
  **BMI**                 \<0.001, 0.91 (0.87-0.95)               0.081, 0.95 (0.89-1.00)   0.188, 0.96 (0.91-1.02)     NI^[a](#fn6881){ref-type="table-fn"}^   \<0.001, 0.93 (0.89-0.96)   0.196, 0.97 (0.93-1.01)
  **Parity number**       \<0.001, 0.71 (0.63-0.81)               0.011, 0.66 (0.48-0.91)   \<0.001, 0.74 (0.63-0.88)   0.167, 0.85 (0.68-1.06)                 \<0.001, 0.73 (0.66-0.81)   0.025, 0.75 (0.62-0.96)
  **First birth age**     \<0.001, 1.1 (1.05-1.15)                0.129, 1.06 (0.98-1.15)   0.159, 1.06 (0.98-1.16)     NI                                      \<0.001, 1.09 (1.05-1.13)   0.052, 1.07 (0.99-1.15)
  **Employment status**   0.001                                   0.631                     0.023                       0.280                                   \<0.001                     0.500
  Housewife               1 (ref)                                 1 (ref)                   1 (ref)                     1 (ref)                                 1 (ref)                     1 (ref)
  Employed                2.06 (1.33-3.18)                        1.19 (0.59-2.39)          3.71 (1.20-11.43)           1.98 (0.57-6.85)                        2.15 (1.45-3.19)            1.24 (0.67-2.30)
  **Smoking**             0.050                                   0.289                     0.603                       NI                                      0.025                       0.313
  Active Smoker           0.56 (0.32-1.00)                        0.67 (0.32-1.40)          0.77 (0.28-2.08)            NI                                      0.55 (0.33-0.93)            0.73 (0.39-1.35
  No exposure             1 (ref)                                 1 (ref)                   1 (ref)                                                             1 (ref)                     
  **Marital status**      0.031                                   1.000                     0.388                                                               0.021                       1.000
  Married                 0.41 (0.18-0.92)                        0.000                     0.55 (0.14-2.14)            NI                                      0.44 (0.22-0.88)            0.000
  Single                  1 (ref)                                                           1 (ref)                     NI                                      1 (ref)                     
  **Menopausal status**   \<0.001                                 0.001                     \<0.001                     0.116                                   \<0.001                     \<0.001
  Menopaused              0.32 (0.22-0.46)                        0.27 (0.12-0.60)          0.29 (0.15-0.57)            0.43 (0.15-1.23)                        0.30 (0.22-0.42)            0.27 (0.13-0.54)
  Non menopaused          1 (ref)                                 1 (ref)                   1 (ref)                     1 (ref)                                 1 (ref)                     1 (ref)
  **Mammo. purpose**                                                                                                                                            0.018                       0.033
  Screening diagnostic    NA^[a](#fn6881){ref-type="table-fn"}^   NA                        NA                          NA                                      0.66 (0.47-0.93), 1 (ref)   0.51 (0.27-0.95), 1 (ref)

^a^Abbreviations: NI, Not included in the analysis; NA, Not applicable

5. Discussion {#sec39973}
=============

Study results showed that the majority of women were among ACR-BIRADS mammographic density categories II and III. The population of women with dense breasts (density\>50%) were more than those with low breast density (51.9% versus 48.1%). In diagnostic group the proportion of dense breasts was significantly more than the screening ones.

It seems that Iranian population has denser breasts compared to what has been reported in studies in other countries. Wolf et al. ([@A16615R17]) obtained a percentage of 25% dense breasts in the control group versus 37% in the study group. In a case-control study carried out by Saftlas et al. ([@A16615R26]), participants were divided into five density categories (\< 5%, 5-25%, 25-45%. 45-65% and \> 65%) and results revealed that 45% of cases and 32% of controls had mammographic density of 45% and higher ([@A16615R26]-[@A16615R28]). According to our study results, age, BMI, menopausal status, employment status, marital status, age at the first delivery, breast feeding, parity number and smoking showed association with density. Mammographic purpose and symptomatic or asymptomatic conditions were also related with density ([@A16615R29]).

In younger age groups, the percentage of women with high density breasts is more than low density ones. As the age Increases, the breast density decreases is correlated with other studies ([@A16615R16], [@A16615R20], [@A16615R23], [@A16615R26], [@A16615R30], [@A16615R31]) Maximal breast density was observed in the age group 30-50 years old which correlates with their hormonal pattern. Density distribution differences between screening and diagnostic groups may have been due to some other confounding factors, which would affect density; on the other hand, there are theoretically differences between the two groups. Analysis comparing these factors in screening and diagnostic group revealed a significant difference concerning the age, personal history of breast cancer, using HRT and menopausal status. Among all these factors only age and menopausal status were associated with density which suggests that age and menopausal status may play a role as a confounder on the difference between diagnostic and screening group. Logistic regression test verified this claim. In other words diagnostic group contains dense breasts because it includes younger women and more proportion of premenopausal ones ([@A16615R11], [@A16615R32], [@A16615R33]).

Unlike parity and menopausal status, age was not independently associated with density. It seems that parity and menopausal status confound the relation of age and density, as claimed by Modugo et al. ([@A16615R30]). They have shown by adjusting parity and BMI, no significant association between age and breast density were presented ([@A16615R34]).

Unlike Modugo et al. ([@A16615R30]) who demonstrated no association between density and breast feeding in Unites States, we found that the breast density was significantly more in those who had never experienced breast feeding and this suggests that breast feeding may change breast cancer risk by changing the breast density. Considering the fact that the mean parity number of women in developing countries is more than that reported in the United States, the above conflict is debatable. Thus, we suggest further studies focused on how duration of breast feeding affects the breast density. By comparing the mean age, no significant difference between those with and without breast feeding was observed ([@A16615R35], [@A16615R36]).

Breast density of premenopausal women was more than menopause group which can be due to the hormonal pattern. Regarding to this fact, we expected to discover an association between the use of HRT/OCP and breast density, as recommended in other studies ([@A16615R20], [@A16615R24], [@A16615R31]), but we did not. Because of limited number of hormone users in our study, besides the infeasibility of getting exact information about the certain duration of using hormones, the results are not enough reliable and it is necessary to design studies focusing on this association independently.

The breast density was significantly more among nonsmokers. This may be due to age differences; but mean age of smokers and nonsmokers did not show any significant difference ([@A16615R37]).

Employed women's breast density was significantly higher than housewives without a significant age difference. As most of employed women have physical activity with their hands and academic education, and are under stress more than others, this factors may affect this relationship. There are few authors studying such factors. As an example we can name studies conducted in U.S. ([@A16615R17], [@A16615R26], [@A16615R38]) investigating on education. They proved that smoking and education had a reverse correlation with breast density in menopause women but not in premenopausal ladies ([@A16615R26], [@A16615R39]). According to our study outcomes, smoking seems to have the same effect, but having job associates with an increase in breast density.

Nulliparous women had denser breasts than the others and this difference is significant in woman with higher parity numbers (up to 8). This association can be explained by younger age of nulliparous women and by considering hormonal changes during each pregnancy. Comparing the age difference between these two groups, we found no significant difference ([@A16615R40], [@A16615R41]).

High breast density group showed older age at the first delivery. On the other hand, mean breast density was significantly different in women with the first delivery age older and younger than 20 years old and this difference was significant up to first delivery age of 29. These findings correlate with the effects of first delivery age and breast cancer risk. Other studies ([@A16615R20], [@A16615R26], [@A16615R30], [@A16615R31]) reported similar findings. For example, nulliparity ([@A16615R20], [@A16615R26], [@A16615R31], [@A16615R42]) and first delivery at old age ([@A16615R31]) are proved to be associated with an increase in breast density in menopause and premenopausal women. However some others have denied the association between first delivery age and breast density ([@A16615R17], [@A16615R43]).

Outer study, like other studies ([@A16615R24], [@A16615R26], [@A16615R31]) showed a reverse association between BMI and density. Breast density of those undergone mammography in follicular phase have not shown any significant difference with those in luteal phase and according to our results no specific time is suggested for mammographic examination. But because of pain in premenstrual period, this time is not recommended for mammography examinations.
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